METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES
pharmacoeconomic cost-utility analysis - CUA is at third place by popularity (10% of studies) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis, utility analysis and results assessment. Each of these stages may have impact on theend data reliabilit...
Saved in:
Main Authors: | R. I. Yagudina (Author), I. V. Sorokovikov (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2015-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS
by: R. I. Yagudina, et al.
Published: (2015) -
COST-UTILITY ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS
by: R. I. Yagudina, et al.
Published: (2015) -
Cost-utility analysis: Current methodological issues and future perspectives
by: Mark J C Nuijten, et al.
Published: (2011) -
METHODOLOGICAL BASIS OF STANDARD GAMBLE METHOD USAGE IN QUALITY OF LIFE ASSESSMENT IN PHARMACOECONOMIC RESEARCHES
by: R. I. Yagudina, et al.
Published: (2015) -
COST-EFFECTIVENESS ANALYSIS OVER USE OF TYROSINE KINASE INHIBITORS (TASIGNA AND GLEEVEC) FOR TREATMENT OF CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE AS FIRST-LINE THERAPY FOR DE NOVO PATIENTS
by: R. I. Yagudina, et al.
Published: (2015)